| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.990 | 382 | 0 | 2000 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
phenotype | 0.100 | None | 0.997 | 347 | 0 | 2000 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.997 | 346 | 0 | 2000 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.997 | 345 | 0 | 2000 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
phenotype | 0.100 | None | 0.984 | 322 | 0 | 1998 | 2020 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
phenotype | 0.100 | None | 0.987 | 297 | 0 | 1990 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.989 | 280 | 0 | 2005 | 2020 | ||||||||
|
cholecystokinin | 0.453 | 0.846 | 3.3E-05 |
|
phenotype | 0.100 | None | 1.000 | 259 | 0 | 2010 | 2020 | ||||||||
|
vimentin | 0.372 | 0.846 | 0.71 |
|
phenotype | 0.100 | None | 0.969 | 255 | 0 | 1992 | 2020 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 213 | 0 | 2000 | 2020 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
phenotype | 0.100 | None | 0.979 | 194 | 0 | 1990 | 2019 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
phenotype | 0.100 | None | 0.968 | 188 | 0 | 1995 | 2020 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
phenotype | 0.100 | None | 0.963 | 187 | 0 | 2003 | 2020 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
phenotype | 0.100 | None | 0.984 | 185 | 0 | 2007 | 2020 | |||||||||
|
matrix metallopeptidase 14 | 0.447 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0.978 | 184 | 0 | 1997 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.100 | None | 0.960 | 175 | 0 | 1998 | 2020 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
phenotype | 0.100 | None | 0.975 | 159 | 0 | 1994 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.100 | None | 0.981 | 154 | 0 | 1993 | 2020 | ||||||||
|
mitogen-activated protein kinase 3 | 0.379 | 0.885 | 3.7E-02 |
|
phenotype | 0.100 | None | 0.993 | 140 | 0 | 2002 | 2020 | ||||||||
|
Rac family small GTPase 1 | 0.429 | 0.962 | 0.76 |
|
phenotype | 0.100 | None | 0.979 | 140 | 0 | 2000 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.100 | None | 0.986 | 138 | 0 | 1995 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
phenotype | 0.100 | None | 0.977 | 131 | 0 | 2004 | 2020 | ||||||||
|
basigin (Ok blood group) | 0.458 | 0.769 | 2.6E-05 |
|
phenotype | 0.100 | None | 0.992 | 127 | 0 | 1993 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.100 | None | 0.984 | 126 | 0 | 1993 | 2020 | ||||||||
|
microRNA 145 | 0.431 | 0.846 |
|
phenotype | 0.100 | None | 0.992 | 122 | 0 | 2010 | 2019 |